New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Stoke Therapeutics, Inc.
STOK
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

635M

Biotechnology

Next Earning date - 05 Nov 2024

635M

Biotechnology

Next Earning date - 05 Nov 2024

12.06USD
Shape-0.46 ( -3.67%)
favorite-chart

Relative Strenght

96
favorite-chart

Volume Buzz

-68%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

31%

Quote Panel

Shape
Updated October 24, 2024
1W -7.23 % 1M -5.49 % 3M -17.17 % 1Y 244.57 %

Key Metrics

Shape
  • Market Cap

    634.93M


  • Shares Outstanding

    52.65M


  • Share in Float

    41.36M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    12.06


  • Average Volume

    544950


  • Beta

    0.965


  • Range

    3.35-17.58


  • Industry

    Biotechnology


  • Website

    https://www.stoketherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

41.65x

P/S Ratio

2.75x

P/B Ratio

0.0

Debt/Equity

-683.3%

Net Margin

$-2.2

EPS

How STOK compares to sector?

P/E Ratio

Relative Strength

Shape

STOK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$16M

Shape228%

2025-Revenue

$2.53

Shape-451%

2025-EPS

$3M

Shape111%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

upgrade

Previous: Not converted

2024-03-26

Now: Buy

Bank of America Securities

upgrade

Previous: Not converted

2023-05-01

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.66
vs -0.61

Q4.22

arrow
arrow

N/A

-0.65
vs -0.66

Q1.23

arrow
arrow

N/A

-0.53
vs -0.66

Q2.23

arrow
arrow

N/A

-0.69
vs -0.63

Q3.23

arrow
arrow

N/A

-0.55
vs -0.66

Q4.23

arrow
arrow

N/A

-0.60
vs -0.65

Q1.24

arrow
arrow

N/A

-0.57
vs -0.53

Q2.24

arrow
arrow

N/A

-0.46
vs -0.69

Q3.24

arrow
arrow

N/A

-0.54
vs -0.55

Q4.24

arrow
arrow

N/A

-0.56
vs -0.60

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

2.9M  vs NA

Q4.22

arrow
arrow

NA

3.3M  vs NA

Q1.23

arrow
arrow

+72%

5.2M  vs 3M

Q2.23

arrow
arrow

-177%

-2481000.00  vs 3.2M

Q3.23

arrow
arrow

+14%

3.3M  vs 2.9M

Q4.23

arrow
arrow

-14%

2.8M  vs 3.3M

Q1.24

arrow
arrow

-18%

4.2M  vs 5.2M

Q2.24

arrow
arrow

+295%

4.8M  vs -2481000

Q3.24

arrow
arrow

+10%

3.6M  vs 3.3M

Q4.24

arrow
arrow

+17%

3.3M  vs 2.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vs -0.10

Q4.22

arrow
arrow

-12%

-0.12
vs -0.12

Q1.23

arrow
arrow

-9%

-0.09
vs -0.12

Q2.23

arrow
arrow

-16%

-0.16
vs -0.09

Q3.23

arrow
arrow

-14%

-0.14
vs -0.16

Q4.23

arrow
arrow

-17%

-0.17
vs -0.14

Q1.24

arrow
arrow

-19%

-0.19
vs -0.17

Q2.24

arrow
arrow

-11%

-0.11
vs -0.19

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

105

105
vs 94

12%

Q4.22

arrow
arrow

109

109
vs 105

4%

Q1.23

arrow
arrow

99

99
vs 109

-9%

Q2.23

arrow
arrow

106

106
vs 99

7%

Q3.23

arrow
arrow

100

100
vs 106

-6%

Q4.23

arrow
arrow

83

83
vs 100

-17%

Q1.24

arrow
arrow

110

110
vs 83

33%

Q2.24

arrow
arrow

116

116
vs 110

5%

Earnings Growth

Latest News